Preclinical scenario of targeting myocardial fibrosis with chimeric antigen receptor (CAR) immunotherapy.
Ferrer-Curriu G, Soler-Botija C, Charvatova S, Motais B, Roura S, Galvez-Monton C, Monguió-Tortajada M, Iborra-Egea O, Emdin M, Lupón J, Aimo A, Bagó JR, Bayés-Genís A.
Ferrer-Curriu G, et al. Among authors: charvatova s.
Biomed Pharmacother. 2023 Feb;158:114061. doi: 10.1016/j.biopha.2022.114061. Epub 2022 Dec 8.
Biomed Pharmacother. 2023.
PMID: 36495661
Free article.
Review.